Pfizer
Caroline Roan has extensive experience in public health and sustainability, currently serving as Chief Sustainability Officer, Senior Vice President of Global Health & Social Impact, and President of The Pfizer Foundation at Pfizer since September 2008. Caroline has held various leadership roles at Pfizer, including Vice President of Global Health & Patient Access and Vice President of Corporate Responsibility. Prior experience includes serving as a Program Associate at the Robert Wood Johnson Foundation and roles at Yale University as Associate Director of the Department of Epidemiology & Public Health and Study Coordinator at the School of Medicine. Caroline began career as a Research Assistant at Brandeis University. Caroline holds a BA in Sociology/Anthropology from Earlham College and an MPA from Columbia University's School of International and Public Affairs.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.